[Gelatinous tear substitutes and nonspecific eye ointments in the critical care unit and in perioperative use].
The effect of Vidisic (a new jelly artificial tear solution) and an ointment basing on Dexpanthenol on the tear production and the tear film stability was studied both on patients in the intensive care units (ICU) and during operations. In 10 relaxed and ventilated patients of the ICU there was no significant change in the tear production after application of either therapy. In 30 patients, undergoing surgery in endotracheal anaesthesia, the break-up-time and the test according to Schirmer were measured pre- and postoperatively. Like in the ICU-patients no difference in tear production could be found. Regarding the stability of the precorneal tear film however Vidisic was more effective than ointment basing on Dexpanthenol. Especially this clear jelly artificial tear solution allowed in contrast to the ointment a permanent and reliable judgement of the pupillary reaction. In addition the patients felt more comfortable with Vidisic.
Universitäts-Augenklinik Ulm.
R
R
Marquardt
T
T
Christ
P
P
Bonfils
D000179:Acrylates / Q000008:administration & dosage*; D000328:Adult; D003231:Conjunctivitis / Q000517:prevention & control*; D003422:Critical Care; D005260:Female; D006801:Humans; D008297:Male; D009824:Ointments; D009883:Ophthalmic Solutions; D010205:Pantothenic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011183:Postoperative Complications / Q000517:prevention & control*; D012636:Secretory Rate / Q000187:drug effects; D013666:Tears / Q000378:metabolism
D000179:Acrylates; D009824:Ointments; D009883:Ophthalmic Solutions; C049065:vidisic; D010205:Pantothenic Acid; C007288:dexpanthenol
Gelartige Tränenersatzmittel und unspezifische Augensalben auf Intensivstationen und in der perioperativen Anwendung.